S
Sverre E. Kjeldsen
Researcher at University of Oslo
Publications - 771
Citations - 95426
Sverre E. Kjeldsen is an academic researcher from University of Oslo. The author has contributed to research in topics: Blood pressure & Left ventricular hypertrophy. The author has an hindex of 94, co-authored 735 publications receiving 89059 citations. Previous affiliations of Sverre E. Kjeldsen include University of Michigan & Cornell University.
Papers
More filters
Journal ArticleDOI
Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers.
TL;DR: From the beginning of the pandemic hypertension appeared as one of the most common comorbidities in patients hospitalised with a Covid-19 infection as discussed by the authors, and was the most commonly associated with chronic lung cancer.
Journal ArticleDOI
Effects of posture on serum cholesterol fractions, cholesterol ratio and triglycerides
TL;DR: In 41 healthy men aged 50 fasting serum HDL cholesterol, total cholesterol, LDL + VLDL cholesterol and triglycerides increased after 30 min standing compared to 30 min in the supine position, however, the cholesterol ratio was not influenced by posture and should be evaluated instead of cholesterol fractions if the conditions for blood sampling were not controlled.
Journal ArticleDOI
High heart rate as predictor of essential hypertension: the hyperkinetic state, evidence of prediction of hypertension, and hemodynamic transition to full hypertension.
TL;DR: The presence of elevated heart rate in both hyperkinetic and hypertensive subjects makes it an interesting and easy measurable prognostic marker.
Journal ArticleDOI
Incidence of heart failure in relation to QRS duration during antihypertensive therapy: the LIFE study.
TL;DR: Persistence or development of a prolonged QRS during antihypertensive therapy is associated with an increased likelihood of new-onset heart failure, independent of blood pressure lowering, treatment modality and regression of electrocardiographic LVH in patients with essential hypertension.
Journal ArticleDOI
Clinical Implications of the 2013 ESH/ESC Hypertension Guidelines: Targets, Choice of Therapy, and Blood Pressure Monitoring
TL;DR: Further evidence may be required on BP targets in high-risk patients, and optimal treatment selection based upon individual patient profiles and comprehensive diagnosis using out-of-office BP measurements may improve patient management.